We are now open for enrolment.
Schneider Von Gunn Pharmaceuticals has received Human Research Ethics Committee approval to commence the Genesis Trial. The Genesis Trial is a 4 week double-blind randomised placebo-controlled clinical trial to investigate the efficacy of CBD oil for the management of abdominal pain in patience suffering from Irritable Bowel Syndrome (IBS).
Minimum requirements to apply:
Must be at least 18 years of age at the time of consent.
Meets Rome IV criteria for IBS.
The abdominal pain should be present for at least 1 day per week for the last 3 months and the origin of the symptoms should be at least 6 months prior.
For more information or to apply, please fill out the form below.